These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 32093886)
1. Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT. Miyauchi Y; Kurita A; Yamashita R; Takamatsu T; Ikushiro S; Mackenzie PI; Tanaka Y; Ishii Y Biochem Biophys Res Commun; 2020 Apr; 525(2):348-353. PubMed ID: 32093886 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation. Kurita A; Miyauchi Y; Ikushiro S; Mackenzie PI; Yamada H; Ishii Y J Pharmacol Exp Ther; 2017 May; 361(2):199-208. PubMed ID: 28228532 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation. Ishii Y; Miyoshi A; Watanabe R; Tsuruda K; Tsuda M; Yamaguchi-Nagamatsu Y; Yoshisue K; Tanaka M; Maji D; Ohgiya S; Oguri K Mol Pharmacol; 2001 Nov; 60(5):1040-8. PubMed ID: 11641432 [TBL] [Abstract][Full Text] [Related]
4. Purification of a phenobarbital-inducible UDP-glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation. Oguri K; Kurogi A; Yamabe K; Tanaka M; Yoshisue K; Ishii Y; Yoshimura H Arch Biochem Biophys; 1996 Jan; 325(2):159-66. PubMed ID: 8561493 [TBL] [Abstract][Full Text] [Related]
5. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids. Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279 [TBL] [Abstract][Full Text] [Related]
6. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1. Ishii Y; Takami A; Tsuruda K; Kurogi A; Yamada H; Oguri K Drug Metab Dispos; 1997 Feb; 25(2):163-7. PubMed ID: 9029046 [TBL] [Abstract][Full Text] [Related]
7. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. King CD; Rios GR; Green MD; MacKenzie PI; Tephly TR Drug Metab Dispos; 1997 Feb; 25(2):251-5. PubMed ID: 9029056 [TBL] [Abstract][Full Text] [Related]
8. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. King C; Tang W; Ngui J; Tephly T; Braun M Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973 [TBL] [Abstract][Full Text] [Related]
9. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin. Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534 [TBL] [Abstract][Full Text] [Related]
10. Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties. Ohno S; Kawana K; Nakajin S Drug Metab Dispos; 2008 Apr; 36(4):688-94. PubMed ID: 18187562 [TBL] [Abstract][Full Text] [Related]
11. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver. Mano Y; Usui T; Kamimura H Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261 [TBL] [Abstract][Full Text] [Related]
12. Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31: cDNA cloning, expression and initial characterization of morphine metabolism. Hamamoto-Hardman BD; Baden RW; McKemie DS; Knych HK Vet Anaesth Analg; 2020 Nov; 47(6):763-772. PubMed ID: 32933848 [TBL] [Abstract][Full Text] [Related]
13. Repeated exposure to codeine alters morphine glucuronidation by affecting UGT gene expression in the rat. Antonilli L; De Carolis L; Brusadin V; Togna AR; Dovizio M; Togna GI; Patrignani P; Nencini P Eur J Pharmacol; 2012 Oct; 693(1-3):7-14. PubMed ID: 23010468 [TBL] [Abstract][Full Text] [Related]
14. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig. Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421 [TBL] [Abstract][Full Text] [Related]
15. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes. Ikushiro S; Emi Y; Iyanagi T Biochemistry; 1997 Jun; 36(23):7154-61. PubMed ID: 9188715 [TBL] [Abstract][Full Text] [Related]
16. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347 [TBL] [Abstract][Full Text] [Related]
17. In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat. Antonilli L; Brusadin V; Milella MS; Sobrero F; Badiani A; Nencini P Biochem Pharmacol; 2008 Sep; 76(5):672-9. PubMed ID: 18639530 [TBL] [Abstract][Full Text] [Related]
18. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134 [TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases. Narayanan R; LeDuc B; Williams DA Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263 [TBL] [Abstract][Full Text] [Related]
20. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]